FDA Issues Letter Regarding Safety Concerns With Paclitaxel-Coated Devices
The FDA has issued a letter to healthcare providers that they should monitor patients with a type of peripheral arterial disease who have been treated with vascular balloons that were coated with paclitaxel or stents that release paclitaxel in the femoropopliteal artery in the leg.
Source: OncLive